Mark Attanasio
Managing Partner @ Crescent Capital Group
Los Angeles, United States
Mark Attanasio is a seed investor at Crescent Capital Group in Los Angeles focused on Mobile and Sports. Mark Attanasio is the Managing Partner at Crescent Capital Group.
- Total investments:
- 5
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Mark Attanasio invests in
Stages Mark Attanasio invests in
Countries Mark Attanasio invests in
Round sizes
Round size
- Series B
- $35M–$35M
Investment Focus
Industry
- Mobile 1 (20%)
- Sports 1 (20%)
- Charity 1 (20%)
- Software 1 (20%)
- Celebrity 1 (20%)
Stage
- Seed 2 (40%)
- Angel 1 (20%)
- Series B 1 (20%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
ON
|
Our ChatOS platform empowers brands and connects fans in new and interesting ways to what they like, what they’re passionate about, and what they’re craving to discover. | $35M / Series B / Dec 06, 2022 | |
|
ON
|
Our ChatOS platform empowers brands and connects fans in new and interesting ways to what they like, what they’re passionate about, and what they’re craving to discover. | $35M / Series B / Dec 06, 2022 | |
Remedy
|
Remedy is a prescriptive chronic care analytics platform employing artificial intelligence to help value-based health systems determine who should get what care, when, how, and by whom to maximize patient health outcomes per dollar spent. We are a design-driven company with core medical AI technology capable of diagnosing disease, catching hiddenhigh-risk diagnoses, and projecting the development of patient’s health into the future. Built around our core AI engine, our first product Remedy Sentinel helps value-based providers identify hidden chronic, co-morbid conditions and intervene by engaging high-risk patients prior to onset. We envision a world where healthcare marries the science of “health” with the art of “care”: scientific, data-driven decision making drives the best outcomes for each individual patient, and frees providers to focus on applying their human touch.Remedy combines novel artificial intelligence algorithms for predictive medical analytics with a healthcare-optimized product development process to give leaders the tools they need to transform their delivery networks and thrive in a value-based care environment. With this approach, Remedy builds a scalable suite of products that, when deployed, learn from experience, and grow into a solution optimized to fit the needs of specific provider groups and the populations they serve.Remedy systematically maximizes the patient health outcome achieved with each dollar spent by using AI to help determine what care is delivered to whom, when it is delivered, where it is delivered, how it is delivered, followed, and supported, and who should deliver it. We not only surface insights, but also build the necessary tools and helps coordinate step-by-step implementation processes to affect real change. | Seed / Aug 01, 2018 | |
Prizeo
|
Platform for influencers to fundraise for their favorite causes through the offering of once-in-a-lifetime experiences and rewards to their fans. Prizeo has already worked with top celebrities such as Kobe Bryant, One Direction, Muhammed Ali, Kristen Bell, and Alicia Keys. | $2.5M / Seed / Jun 06, 2013 | |
Everest
|
Everest is a SNS-based mobile app that enables users to share photos and experiences about the adventures and journeys in life. The app is available for download at the Apple Store. | $1.7M / Angel / Apr 01, 2013 |
Co-Investors
B3 Capital
2 deals together
GreatPoint Ventures
2 deals together
Mighty Capital
2 deals together
Mirae Asset Venture Investment
2 deals together
Quest Venture Partners
2 deals together
Alsop Louie Partners
1 deal together
About Crescent Capital Group
Crescent Capital Group is a global alternative investment firm that operates and invests in alternative and private-credit funds.
Crescent Capital Group Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mark Attanasio
Managing Partner
|
|||
Raymond Barrios
Vice President
|
|||
Jean-Marc Chapus
Co-Founder and Managing Partner
|
|||
|
Kenneth McRay
Senior Vice President
|
|||
Kimberly S. Bartholomew
Associate
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Mark Attanasio invest in?
Mark Attanasio invests primarily in Mobile, Sports and Charity startups, most often at Seed and Angel stage. Most of the 5 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Mark Attanasio's check size?
Mark Attanasio typically joins rounds of $35M–$35M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Mark Attanasio participates in.
When did Mark Attanasio last invest?
The most recent investment recorded for Mark Attanasio closed in Dec 2022. Shizune tracks 5 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
